IPPCR 2019 Overview of Hypothesis Testing Part 2 of 5

IPPCR 2019 Overview of Hypothesis Testing Part 2 of 5

Understanding Hypothesis Testing: P-Value and Bayesian Approach

Introduction to the Experiment

  • Paul Wakim introduces himself as the chief of Biostatistics and Clinical Epidemiology Service at NIH, discussing the focus on p-values and Bayesian approaches in hypothesis testing.
  • An experiment is set up involving two coins: one regular coin (heads/tails) and one with two heads. The audience is invited to choose a coin without knowing which is which.

Setting Up Hypotheses

  • The chosen coin will be tossed, and results will be shared without revealing the true state of the coin, mimicking scientific research where data informs inference.
  • The null hypothesis (H0) posits that the regular coin was selected, while the alternative hypothesis (H1) suggests it’s the two-headed coin. There’s an initial equipoise between these hypotheses.

Importance of Decision-Making

  • Emphasizes that making a decision based on experimental results has significant public health implications; errors can lead to major consequences.
  • Highlights urgency in decision-making due to potential life-and-death situations, along with financial costs associated with experiments.

Conducting Coin Tosses

  • After tossing once and getting heads, participants are asked if they would reject H0. Most likely, they wouldn’t conclude it's a two-headed coin based on just one toss.
  • As more tosses yield heads (up to seven), participants are prompted to consider how many heads would convince them that they have a two-headed coin.

Understanding P-values

  • Introduces p-values as probabilities reflecting how likely observed outcomes would occur under H0. For example, getting one head from one toss has a p-value of 0.5.
  • Discusses how low p-values indicate questioning H0; for instance, obtaining seven heads out of seven tosses yields a p-value of 0.008—suggesting strong evidence against H0.

Conclusion on Hypothesis Testing

  • Concludes that if data shows very low probability under H0 assumptions (like 7 heads), researchers should reconsider their assumption about which coin was tossed.

Understanding P-Values and Bayesian Approach in Statistics

Misinterpretations of P-Values

  • The speaker discusses the misconception that obtaining seven heads from a coin toss proves it is a two-headed coin, emphasizing that this result could still occur by chance with a regular coin.
  • Clarifies that 0.008 represents the probability of getting seven heads if using a regular coin, not the likelihood of it being a regular or two-headed coin.
  • Defines p-value formally as the probability of obtaining results as extreme or more extreme than observed, assuming the null hypothesis (H0) is true.

Introduction to Bayesian Thinking

  • Introduces the Bayesian approach as intuitive, reflecting how people update their beliefs based on new observations.
  • Describes the process of starting with a prior belief, gathering data, and forming an updated posterior belief through continuous learning and observation.

Updating Beliefs in Bayesian Framework

  • Explains how posterior beliefs evolve into prior beliefs as new data is collected; this cycle continues indefinitely in life but concludes in clinical trials when sufficient evidence is gathered.
  • Discusses applying this updating process at both individual patient levels and group levels during clinical trials.

Differences Between Bayesian and Frequentist Approaches

  • Highlights that Bayesians view probabilities (like p for getting heads) as variables subject to change based on evidence, while Frequentists see them as fixed once a specific scenario (coin choice) is established.
  • Illustrates that stating "it's a regular coin" equates to saying "the probability of heads is one half," showing how both concepts are interconnected.

Probability Distribution Updates

  • Emphasizes that even after selecting a coin, uncertainty remains about its nature; thus, assigning probabilities reflects this uncertainty according to Bayesians.
  • Reiterates that asking about chances related to either type of coin translates into questioning the respective probabilities associated with each outcome.

Practical Application of Bayesian Updates

  • Starts with equal prior beliefs regarding both coins' likelihood before any tosses are made; initial assumptions set at p = 1/2 for regular and p = 1 for two-headed coins.

Understanding Bayesian Probability vs. P-Value

Key Differences Between Bayesian Probability and P-Value

  • The Bayesian posterior probability of the regular coin is initially 0.333, decreasing to 0.008 after seven tosses, highlighting how evidence impacts belief in hypotheses.
  • It is crucial to differentiate between the concepts of p-value and Bayesian probability; they are calculated differently and have distinct statistical definitions.
  • After observing seven heads in seven tosses, the belief shifts significantly: there's only a 0.8% chance it's a regular coin versus a 99.2% chance it’s a two-headed coin.

Comparison of Tables for P-Value and Bayesian Approach

  • Two tables illustrate different methodologies: one for p-values (number of tosses) and another for Bayesian updates (toss number), emphasizing their differing approaches to data interpretation.
  • Despite being fundamentally different concepts, the numerical outcomes from both methods can appear similar, which may lead to confusion regarding their interpretations.

Misinterpretation of P-Values

  • The p-value represents the probability of obtaining results as extreme or more extreme than observed under the null hypothesis; it does not indicate the likelihood that the null hypothesis is true.
Video description

IPPCR 2019 Overview of Hypothesis Testing Part 2 of 5 Air date: Tuesday, October 1, 2019, 12:00:00 PM Category: IPPCR Runtime: 00:21:11 Description: The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues. For more information go to https://ocr.od.nih.gov/courses/ippcr.html Author: Paul Wakim, PhD Permanent link: https://videocast.nih.gov/launch.asp?28842